µÚËľüÒ½´óѧһ¾Å¾ÅÈýÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ r}|a*dh'R
n7,LfO#
ѧ¿Æ×¨Òµ: ´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ Wo,fHY
$sb `BS
¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ xX\A&9m
9@ 8)ZHf
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© r^ +n06[
FK,Jk04on
1. CD4 F=V_ACU
l/6(V:
2. T cell receptor(TCR) F5YHc$3^
'9Xw_1B
3. immunoglobulin superfamily (IgSF) ~.<}/GP] _
xi! R[xr1
4. selectin W%P0X5YQ
o;J_"'kP
5. anti-idiotypic antibody (¦ÁId) =d1R9O
%^<A`Q_
6. major histocompatibility complex(MHC) nISfRXU;
8
2~ZPZG
7. immunotolerance vV /fTO
D>I|(B!.p8
8. biological reponse modifier(BRM) he1OLk
JnBg;D|)@
9. immune reponse gene (Ir gene) uY*|bD`6&
o
_DZ
10. reshaped antibody (or reconstituted antibody) zFGZ;?i
"\u_gk{g
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© pm~uWXqxr=
VS_xC$X!S
1. ¼òÊö°×ϸ°û½éËØ6(IL-6)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¡£ ~pj/
_@S@x
y|E{]
2. ϸ°û¶¾ÐÔTÁܰÍϸ°û(Tc»òCTL)Ó뿹ÌåÒÀÀµµÄϸ°û½éµ¼µÄϸ°û¶¾(ADCC)ɱÉË»úÀíÓкβ»Í¬? 4'ymPPY
kqie|_y
3. ¼òÊöµÚ¢ôÐÍ(³Ù·¢ÐÍ)±ä̬·´Ó¦µÄ·¢Éú»úÀí¡£ 0(~,U!g[=
3gzcpFNqX
4. NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄ±íÃæ±ê¼Ç?NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄÉúÎïѧ»îÐÔ? FD*w4U5
;p}X]e l
}
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö) GMO|A.bzzN
]jL`*tI\S
¹©´«È¾²¡Ñ§×¨ÒµÊÔÌ⣺ Q #%C)7)
h#iFp9N
1. »úÌåÓÐÄÄЩÃâÒßϸ°ûºÍÃâÒß·Ö×Ó²ÎÓ뿹²¡¶¾¸ÐȾ?ËüÃÇÊÇÈçºÎ·¢»Ó²¡¶¾ÃâÒß×÷ÓõÄ? >9v?p=
(Mw<E<f
2. Ŀǰµ¥¿Ë¡¿¹ÌåÔÚ²¡¶¾Ñ§ÖÐÓÐÄÄЩÖ÷ÒªÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? #r4S%
#FfUkV
¡¡ 0$9I.%4jAJ
yb(zyGe
¹©Ïû»¯ÄÚ¿Æ×¨ÒµÊÔÌ⣺ r ]cC4%in
LBlaDw
1. ĿǰÌåÄÚºÍÌåÍâ¼ì²âÖ×Áö»¼ÕßÃâÒß¹¦Äܵķ½·¨Ö÷ÒªÓÐÄÄЩ?·Ö±ðÐðÊöÿÖÖ·½·¨µÄÔÀíºÍ½á¹û²â¶¨? A
S#D9o
%7$oig\wE
2. Ŀǰµ¥¿Ë¡¿¹ÌåÔÚÖ×ÁöѧÖÐÓÐÄÄЩÖ÷ÒªµÄÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ?OU+)kgzh
&@dWd
µÚËľüÒ½´óѧһ¾Å¾ÅËÄÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ sH>Z{xjr
p?X`f#
ѧ¿Æ×¨Òµ: ´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ T F !Lp:
oy-Qy
¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ ] Qp0|45=
Sdc;jK 9d!
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© ~%4#R4&
>sE5zj|V
1. CD8 P]Z}%
8^O
)T6+}
2. T cell receptor ¦Á and ¦Â chain (TCR¦Á¦Â ) a4
g~'^uC
jZ <*XX
3. immunoglobulin fold(Ig fold) ~BVg#_P
$S$%avRX
4. cadherin (Ca-dependent cell adhesion moleculers) AM}-dKei|
R
Nr=M^Zn
5. idiotype-anti-idiotypic antibody immune network theory >RxZ-.,a
17G7r\iNYq
6. HLA class II antigen FuaGr0]
^HKxaW9W
7. complementarity-determining region (CDR) ||7r'Q
dL")E|\\k
8. perforin(or pore-forming protein ,PFP) MQ"<r,o?:
J?5O2n
9. high affinity IL-2 receptor 2o/}GIKj
kaUH#;c>_
10. artificial active immunization 6R@
v>}
x&)P)H0vn
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© cX1"<f
D o
pz?.(AmU\
1. ¼òÊö°×ϸ°û½éËØ2(IL-2)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¼°ÆäÔÚÁÙ´²ÖÎÁÆÖеÄÓ¦ÓᣠoHu0] XA
_}`iLA!$I
2. Çë±È½ÏµÚ¢ñÐÍ(ËÙ·¢ÐÍ)³¬Ãô·´Ó¦ÓëµÚ¢ôÐÍ(³Ù·¢ÐÍ)³¬Ãô·´Ó¦µÄ·¢²¡Ìص㡣 LtH;#Q
(q*T.
3. ÊÔÊö·ÖÃÚÐÍIgA(secretory IgA)µÄ½á¹¹ÌصãºÍºÏ³É·ÖÃÚ¹ý³Ì¡£ 4jis\W}%L3
S! ,.#e (Y
4. ÊԱȽÏT¡¢BÁܰÍϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(Èç±íÃæ¿¹Ô¡¢±íÃæÊÜÌåµÈ)µÄÒìͬµã¡£ N+!{Bt*
,/:#=TuYm
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö¡£Çë×¢Ò⣺ÿλ¿¼ÉúÖ»ÄÜ´Ó1¡¢2ÌâÖÐѡһÌâ,3¡¢4ÌâÖÐѡһÌâ,¹²´ðÁ½Ìâ,¶à´ðÕß²»¼Æ·Ö¡£) :(A]Bm3
v.\1-Q?
1. Ŀǰ¼ì²âϸ°ûÒò×ÓÖ÷ÒªÓÐÉúÎïѧ»îÐÔ¼ì²â·¨ºÍÃâÒßѧ¼ì²â·¨,Çë¾ÙÀý·Ö±ðÐðÊöÁ½ÖÖ·½·¨µÄʵÑéÔÀí¡£ C/_W>H_
+n^$4f
2. ΪÁ˱ÜÃâIgG¿¹ÌåFc¶Î·ÇÌØÒìÐÔ×÷ÓÃ,³£Ó¦ÓÃθµ°°×øˮ½âµÄF(ab¡¯)2¶Î,ÊÔÎÊÈçºÎÓ¦ÓÃSDS-PAGE·½·¨¶ÔF(ab¡¯)2½øÐмø¶¨? kP6g0,\|a|
.\{GU9|nO
3. ÊÔÊö¿¹Ö×Áö»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ }I,]"0b
~;il{ym
4. ÊÔÊö¿¹²¡¶¾»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ _hA p@?
M
id&;
¡¡ sh:sPzQ%Jv
5RI"gf
b!5W!vcK
µÚËľüÒ½´óѧһ¾Å¾ÅÎåÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ vM1f
-I-
ѧ¿Æ×¨Òµ£ºÃâÒßѧ¡¢´«È¾²¡Ñ§¡¢Ïû»¯ÄÚ¿Æ `kVy1WiY
K.",=\53
¿¼ÊÔ¿ÆÄ¿£ºÃâÒßѧ DZilK:
yFH)PQ_
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© ;l7wme8Qk
/F4rbL^:
1. immunoglobulin gene rearrangement }tua0{N:z
l~!\<, !
2. the common chain of cytokine receptor (or a cytokine receptor k/u6Cw0/
U_wn/wcLS
subunit shared by some cytokine receptors) m3+MRy5
B=jJ+R
3. flow cytometry(FCM) +=)<
Su.
#Ne<=ayS
4. carrier effect <_dyUiT$J
D}>pl8ke~g
5. positive selection of T lymphocytes in thymus [V|,O'X ~
k?;A#L~
6. mouse TH1(Th1) and TH2(Th2) subsets *!$4
X};m \Bz
7. perforin (pore-forming protein ,PFP) v~H1Il_+
zH0%;
o}
8. ADCC(antibody-dependent cell-mediated cytotoxicity) WS/^WxRY
5Q#;4
9. SH-2(src-homology region 2) y>Zvos e
K_{f6c<
10. Ab2¦Â (internal image) -wH#B<'
orVsMT[A
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© M#LQz~E
1t_$pDF}
1. ½üÄêÀ´ÔÚÈËÀà°×ϸ°û·Ö»¯¿¹Ô(CD)Ñо¿ÁìÓòÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? C)~YWx@v
5cO}Jp%PA
2. ²ÎÓë»î»¯Tϸ°ûÓë»î»¯Bϸ°ûÏ໥×÷ÓõķÖ×ÓÖ÷ÒªÓÐÄÄЩ?¼òÊöÆä½á¹¹ºÍ¹¦ÄÜ? )IPnSh/<
BF@(`D&>
3. ÊÔÊöHLAÔÚÁÙ´²ÉϵÄÖ÷ÒªÓ¦Óᣠ9!b,!#=
h#'(i<5v
4. Àý¾ÙÈýÖÖ´ÓÈËÍâÖÜѪµ¥¸öºËϸ°û(PBMC)Öд¿»¯Tϸ°ûµÄ·½·¨,·Ö±ðÐðÊöÆäʵÑéÔÀíºÍÖ÷Òª²Ù×÷²½Öè¡£ Rp4EB:*
hLPg=8nJ_
5. ÆÀ¼Ûºìϸ°ûÉú³ÉËØ(EPO)¡¢¸ÉÈÅËØ(IFN)ºÍ¼¯Âä´Ì¼¤Òò×Ó(CSF)ÔÚÁÙ´²Ä³Ð©¼²²¡µÄÓ¦ÓᣠF,
Y@
wUWSW<
Èý. Ñ¡ÔñÎÊ´ðÌâ(ÿÌâ10·Ö,¹²20·Ö¡£Çë°´±¨¿¼×¨Òµ´ðÌâ,Èç´ð·Ç±¾×¨ÒµÌâ»ò¶à´ðÌâ¾ùÊÓΪÎÞЧ¡£) j}uFp|df<
#/$}zl
ÃâÒßѧרҵ£º AVVL]9b_2
zvf:*Na")
1. ÊÔÊöϸ°ûÒò×ÓÊÜÌåÖÐ,Ig³¬¼Ò×å¡¢ÔìѪÒò×ÓÊÜÌ峬¼Ò×å¡¢Éñ¾Éú³¤Òò×ÓÊÜÌ峬¼Ò×åÒÔ¼°Ç÷»¯Òò×ÓÊÜÌ峬¼Ò×åµÄÖ÷Òª½á¹¹Ìصã,ÿ¸ö³¬¼Ò×åÀý¾Ù³ö2¸ö³ÉÔ±¡£ 'bGL@H
+5H9mk
2. ÊԱȽÏÈËT¡¢BÁܰÍϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(±íÃæ±ê¼Ç)µÄÒìͬµã,ËüÃÇ·Ö±ð²ÎÓëÄÄЩÖ÷ÒªµÄÃâÒß¹¦ÄÜ? "'h?O*V]u{
3p{N7/z(
´«È¾²¡Ñ§×¨Òµ£º vn|u&}h
Z.Lm[$/edn
1. ÈËÀàÃâÒßȱÏݲ¡¶¾(HIV)¸ÐȾÈËÌåºó,ÃâÒß¹¦Äܿɷ¢ÉúÄÄЩÖ÷ÒªµÄ±ä»¯?»úÀíÊÇʲô?ÈçºÎ½øÐÐÏàÓ¦µÄÃâÒßѧ¹¦Äܼì²â£¿ s:lar4>kM
DrLNY"Zq
2. ÇëÆÀÊöÉö×ÛºÏÕ÷³öѪÈȲ¡¶¾(HFRSV)¸ÐȾºó»úÌåÃâÒßѧ±ä»¯µÄÓ벡ÀíËðÉ˵ĹØÏµ¡£ v39`ct= e
q4{Pm $OW
Ïû»¯×¨Òµ£º 1.ÊÔÊöÓëÏû»¯ÏµÍ³ÓйصÄÖ×ÁöÏà¹Ø¿¹ÔÑо¿µÄ½øÕ¹¡£
RR!(,j^M
aSd$;t~
2.¼òÊöճĤÏà¹ØÁܰÍÑù×éÖ¯(mucosal assiociated lymphoid tissue,MALT)µÄ×é³ÉºÍ¹¦ÄÜÌØµã¡£·ÖÃÚÐÍIgAÊÇÈçºÎ½øÐкϳɺͷÖÃÚµÄ? x3=W{Fv@4
8v@6 &ras@
P7QOlTQI
z_R^n#A~r
_6" vPN
} Uki)3(
t^ LXGQ
µÚËľüÒ½´óѧһ¾Å¾ÅÁùÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ,!t1( H
6l&m+!i
ÃâÒßѧÊÔÌâ 16/+ O$#y
KK4>8zGR
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£©
hh<5?1
_?>!Bz
m
1. Fas(CD95)/FasL 7vUfA"
LqIMU4Ex
2. common chain of cytokine receptor |t CD@M
qd{o64;|
3 . TCR/CD3 complex 58zs%+F
h`+Gs{1qw
4. negaive selection of thymocytes z"o;|T:
k$:QpTg[
5. artificial active immune [W=%L:Ea
d='z^vHK
6. anti-idiotypic pC(AM=RY!
@3wI(l[
7. IgSF Q_QmyD~m
wOE_2k
8. Integrin +5Ir=]=T9
AKx\U?ei7
9. chemokine 8F($RnP3
U#G
u
B&V
10. B7/CD28 D}"\nCz}y&
QnZR
¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²60·Ö£© ]w%7/N0R
xp/u, q
1. ±È½ÏMHC¢ñºÍMHC¢òÀ࿹ԲÎÓëµÄ¼Ó¹¤Ìá³Ê¿¹ÔµÄ¹ý³Ì¡£ h 7kyz
:*tv`:;p
2. ±È½ÏCTLºÍNKɱÉ˰Ðϸ°ûʱʶ±ðºÍɱÉË»úÖÆµÄÌØµã¡£ OW)8Z60
gtJ^8khME
3. ±È½ÏÃâÒßѧ¼ì²â·¨ºÍÉúÎïѧ»îÐÔ¼ì²â·¨¼ì²âϸ°ûÒò×ÓµÄÓÅȱµã¡£ 4. ·¢ÏÖÒ»ÖÖеİ×ϸ°û·Ö»¯¿¹Ô»òÖ×ÁöÏà¹Ø¿¹Ô,²¢ÖƱ¸Á˵¥¿Ë¡¿¹Ìå,ÊÔÉè¼ÆÊµÑé·½°¸¿Ë¡´Ë»ùÒò¡£ {ZbeF#*"
[lS'GszA
5. Ñ¡ÔñÏÂÊöÖÐÒ»¸öרÌâ,ÐðÊöÎÒ¹úÔÚÕâÒ»Ñо¿ÁìÓòµÄÏÖ×´¼°ÃæÁÙµÄÌôÕ½1)Ö×ÁöÃâÒߣ»(2)»ùÒòÖÎÁÆ£»(3)CD¿¹Ô¡£ mwbkXy;8
_<